Andrea Natali
Andrea Natali
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
Heart disease and stroke statistics—2017 update
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).
E Ferrannini, A Natali, P Bell, P Cavallo-Perin, N Lalic, G Mingrone
The Journal of clinical investigation 100 (5), 1166-1173, 1997
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial …
H Brunner, JR Cockcroft, J Deanfield, A Donald, E Ferrannini, J Halcox, ...
Journal of hypertension 23 (2), 233-246, 2005
Effect of insulin on uric acid excretion in humans
A Quinones Galvan, A Natali, S Baldi, S Frascerra, G Sanna, D Ciociaro, ...
American Journal of Physiology-Endocrinology And Metabolism 268 (1), E1-E5, 1995
Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity
E Ferrannini, A Natali, B Capaldo, M Lehtovirta, S Jacob, ...
Hypertension 30 (5), 1144-1149, 1997
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
E Muscelli, A Mari, A Casolaro, S Camastra, G Seghieri, A Gastaldelli, ...
Diabetes 57 (5), 1340-1348, 2008
α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population
WE Gall, K Beebe, KA Lawton, KP Adam, MW Mitchell, PJ Nakhle, ...
PLoS One 5 (5), e10883, 2010
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali, E Ferrannini
Diabetologia 49 (3), 434-441, 2006
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
A Gastaldelli, S Baldi, M Pettiti, E Toschi, S Camastra, A Natali, ...
Diabetes 49 (8), 1367-1373, 2000
Effect of insulin on renal sodium and uric acid handling in essential hypertension
E Muscelli, A Natali, S Bianchi, R Bigazzi, AQ Galvan, AM Sironi, ...
American journal of hypertension 9 (8), 746-752, 1996
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy
RA De Blasi, M Ferrari, A Natali, G Conti, A Mega, A Gasparetto
Journal of Applied Physiology 76 (3), 1388-1393, 1994
Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss
M Emdin, A Gastaldelli, E Muscelli, A Macerata, A Natali, S Camastra, ...
Circulation 103 (4), 513-519, 2001
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome
A Natali, S Vichi, P Landi, S Severi, A L'abbate, E Ferrannini
Diabetologia 43 (5), 632-641, 2000
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein
G Basta, AM Sironi, G Lazzerini, S Del Turco, E Buzzigoli, A Casolaro, ...
The Journal of Clinical Endocrinology & Metabolism 91 (11), 4628-4634, 2006
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM
RC Bonadonna, E Bonora, S Del Prato, MP Saccomani, C Cobelli, ...
Diabetes 45 (7), 915-925, 1996
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance
E Ferrannini, A Natali, S Camastra, M Nannipieri, A Mari, KP Adam, ...
Diabetes 62 (5), 1730-1737, 2013
Essential hypertension, metabolic disorders, and insulin resistance
E Ferrannini, A Natali
American heart journal 121 (4), 1274-1282, 1991
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes
A Natali, E Toschi, S Baldeweg, D Ciociaro, S Favilla, L Saccà, ...
Diabetes 55 (4), 1133-1140, 2006
Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes
A Natali, S Baldeweg, E Toschi, B Capaldo, D Barbaro, A Gastaldelli, ...
Diabetes care 27 (6), 1349-1357, 2004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20